Quick Guide to Recent Changes We’ve Made to G2’s Reports
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
The new guidelines offer patients advice on when they should start their screening, and how often they should have it done.
While the rule is not yet final, it’s likely that labs will have to pay more in direct CLIA compliance expenses, starting in October.
Users should realize that the FDA can extend the shelf life of a test when and if it receives additional data supporting such an extension.
For labs, the big takeaway is how prominently molecular testing and profiling figures in so many aspects of the NCCN’s recommendations.
Most healthcare-related enforcement actions from July and August involved urine drug tests and genetic testing.
The process is now slightly less rigged in insurers’ favor.
Ventura County’s organized health system and three medical care providers were accused of falsely billing Medi-Cal.
New Short-read Transpore Rapid Karyotyping test can identify fetal chromosomal abnormalities in a variety of samples.
Technology can make it possible for labs and other healthcare providers to boost revenue while still providing a positive patient experience.
Federal enforcers and whistleblowers home in on billing of medically unnecessary sleep tests.